Product image of Glukóza Braun (Glucose Monohydrate) supplied by GNH India

Glukóza Braun

Active Ingredient:
Glucose Monohydrate
Origin:
EU

Glukóza Braun (Glucose Monohydrate)

Glukóza Braun is a pharmaceutical product that contains the active ingredient glucose monohydrate. It is supplied in an intravenous form for administration directly into the bloodstream. The preparation is manufactured for the European Union market and is used as a source of carbohydrate energy in clinical settings.

Manufacturer / TM Owner

B.Braun Melsungen Ag

1
Pack/s
This product is added to your enquiry list

Request a Quote

Please fill out the form below and our team will get back to you shortly with pricing and further information.

A minimum order value applies. Our team will confirm the exact amount or quantity after reviewing your requirements.

Indications & Clinical Uses

Glukóza Braun is employed in a variety of medical situations where rapid carbohydrate supplementation is required. It is commonly used for:

  • Treating acute hypoglycemia in patients who cannot take oral glucose.
  • Providing an energy source during parenteral nutrition.
  • Supporting glucose levels during surgical procedures and anesthesia.
  • Assisting in the management of electrolyte imbalances when combined with appropriate salts.
  • Serving as a diluent for certain intravenous medications.

Side Effects

Side effects of intravenous glucose monohydrate can vary in frequency and severity.

Common

  • Mild hyperglycemia (elevated blood sugar).
  • Local irritation at the infusion site.
  • Nausea or vomiting.
  • Headache.
  • Transient changes in blood pressure.

Serious

  • Severe hyperglycemia leading to osmotic diuresis.
  • Allergic reactions such as rash or urticaria.
  • Fluid overload, especially in patients with cardiac or renal impairment.
  • Electrolyte disturbances, particularly hyponatremia.
  • Hypoglycemia rebound after abrupt discontinuation.

Precautions & Warnings

When using Glukóza Braun, clinicians should consider several safety measures. Important precautions include:

  • Assessing baseline blood glucose and monitoring levels during infusion.
  • Adjusting infusion rates in patients with diabetes, renal failure, or heart failure.
  • Avoiding rapid infusion in neonates and infants due to risk of hyperosmolar injury.
  • Ensuring compatibility with other intravenous solutions to prevent precipitation.
  • Using aseptic technique to reduce infection risk.
  • Reviewing patient history for known hypersensitivity to glucose preparations.

Avoid Interactions

Glukóza Braun may interact with other medications or clinical conditions. Interactions to note are:

Avoid

  • Co-administration with high-dose insulin without close glucose monitoring.
  • Simultaneous infusion of calcium-containing solutions that may precipitate.

Use with caution

  • Concurrent use of diuretics that affect fluid balance.
  • Medications that alter blood glucose, such as sulfonylureas or glucocorticoids.
  • Electrolyte supplements, especially potassium, due to shifts in serum levels.
  • Anesthetic agents that can influence glucose metabolism.

Frequently Asked Questions

Glukóza Braun contains glucose monohydrate as its sole active ingredient.

It is commonly used to treat acute hypoglycemia, support energy needs during parenteral nutrition, and maintain glucose levels during surgery or anesthesia.

Glukóza Braun is administered intravenously, meaning it is infused directly into the bloodstream through a vein.

Yes, but blood glucose levels should be closely monitored and infusion rates adjusted to avoid hyperglycemia.

Common side effects include mild hyperglycemia, local irritation at the infusion site, nausea, headache, and temporary blood pressure changes.

Serious reactions may include severe hyperglycemia, allergic rash or urticaria, fluid overload, electrolyte disturbances, and rebound hypoglycemia after abrupt discontinuation.

Rapid infusion should be avoided in neonates and infants because of the risk of hyperosmolar injury to delicate tissues.

Mixing with calcium-containing solutions can cause precipitation, so it should be avoided.

Caution is advised when using diuretics, insulin, sulfonylureas, glucocorticoids, and certain electrolyte supplements.

Blood glucose should be measured before starting the infusion and at regular intervals throughout the therapy, according to clinical protocols.

The regulatory status varies by country; in many regions it is supplied under medical supervision rather than as an over‑the‑counter product.

The infusion should be stopped immediately, and appropriate medical treatment for the allergic reaction should be initiated.

Published by

GNH India Pharmaceuticals Limited

Licensed pharmaceutical supplier

Last updated:

Disclaimer

At GNH India, we aim to provide information that is expert-reviewed, accurate, and reliable. However, all content on this platform is intended for general informational purposes only and does not constitute professional medical advice, diagnosis, or treatment. While efforts are made to maintain accuracy and currency, the information may contain errors, omissions, or may not reflect the latest developments. Always consult a qualified healthcare professional regarding any medical concerns.

All product names, brand names, trademarks and registered trademarks displayed on this website are the property of their respective owners. This website and its operator are not affiliated with, endorsed by, or authorized by any such trade mark owners unless expressly stated. Any reference to product names or trademarks is made solely for descriptive and informational purposes. No commercial relationship, sponsorship, approval, or association with any trademark owner should be inferred. Information provided herein does not constitute promotion, advertising, or an offer for sale of any medicinal product and is intended solely for general informational purposes.

All trademarks and brand names displayed on this website are used strictly in accordance with the provisions of the Trade Marks Act, 1999, specifically Sections 30 and 30(1) governing fair use. Trademark ownership has been accurately attributed under the "Manufacturer/ TM Owner" section in compliance with statutory requirements.

Ordering Process

Simple, Secure, and Seamless

Learn how our streamlined ordering process guarantees fast, compliant, and reliable access to essential medicines worldwide.

Quote request form

01

Submit Quote Request Form

Tell us what medications you need by filling out our simple form and uploading a valid document.

Price estimate review

02

We Review & Send Estimate

Our licensed pharmacists will verify your details and provide you with a detailed cost estimate.

Secure payment

03

Confirm & Make Payment

Discuss any queries, approve the estimate, and complete your payment.

Worldwide delivery

04

Get Delivered

Your medicines, safely packed and delivered to your door or nearest airport — hassle-free.

Quality You Can Trust

Our internationally recognized certifications underscore our commitment to safety, quality, and excellence.